Company Filing History:
Years Active: 1978-1981
Title: **Herbert H. Reller: Innovator in Analgesic and Anti-Inflammatory Compounds**
Introduction
Herbert H. Reller is a prominent inventor based in Cincinnati, OH, who has made significant contributions to the field of therapeutic compounds. With a total of four patents to his name, his work focuses on developing innovative solutions for pain relief and inflammation management. His expertise in pharmacology and formulation science has positioned him as a key player in the pharmaceutical industry.
Latest Patents
Reller's latest patents reflect his commitment to advancing pain management solutions. One of his notable inventions includes compounds and compositions that utilize dihydroxybenzoic acid derivatives. These compounds have shown promise for topical application, providing analgesic, anti-pyretic, and anti-inflammatory effects. Additionally, Reller has developed topical anti-inflammatory compositions specifically designed for the administration of acetylsalicylic acid to inflamed tissue, presenting new methods for effective pain relief.
Career Highlights
Throughout his career, Herbert H. Reller has developed a robust portfolio of patents that contribute to the pharmaceutical landscape. He has been an integral part of The Procter & Gamble Company, which has been instrumental in bringing his innovative ideas to market. His work continues to influence the development of safe and effective pharmaceutical products.
Collaborations
Reller collaborates closely with Herbert C. Kretschmar, sharing insights and research that advance their mutual interests in pharmacological innovations. Their partnership exemplifies the collaborative spirit essential in the realm of research and development, fostering the creation of impactful medical solutions.
Conclusion
Herbert H. Reller’s contributions to analgesic and anti-inflammatory compounds highlight his role as a leading inventor in the pharmaceutical field. With his innovative spirit and collaborative endeavors, Reller is paving the way for enhanced therapeutic options that can greatly improve patient care and quality of life. His ongoing work at The Procter & Gamble Company signifies a promising future for his research and inventions.